Febuxostat cas:1440...

Febuxostat cas:144060-53-7

Febuxostat cas:144060-53-7

Min.Order / FOB Price:Get Latest Price

0 Metric Ton

Negotiable

  • Min.Order :0 Metric Ton
  • Purity: 99%
  • Payment Terms : L/C,D/A,D/P,T/T,Other

Keywords

Febuxostat 144060-53-7 Adenuric

Quick Details

  • Appearance:White crystalline powder
  • Application:Suitable for high uric acid hematic disease presenting with symptoms of gout treatment
  • PackAge:25Kg/drum,5KG/Aluminum foil bag,1KG/Aluminum foil bag
  • ProductionCapacity:|Metric Ton|Day
  • Storage:keep in cool and dried place
  • Transportation:by sea/air

Superiority:

              
1, Full experience of large numbers containers loading in main Chinese seaports 
2, Packing with pallet as buyer's special request 
3, Best service after shipment with e-mail 
4, Cargos together with container sales seervice available 
5, Rich experience for exporting
6, Cargos photo before and after loading into container
7, Raw materials from chinese origin
8, Top Pharm Chemical Group are strong in the field of 
  Pharmaceuticals,food additives, plant extract and fine chemicals for more than 10 years.

Details:

USP2010 Top Quality Febuxostat

 

CAS.No.:  144060-53-7

Appearance:   Off- white to white crystalline powder 

 

Product Name: Febuxostat
Synonyms : 2-[3-Cyano-4-isobutoxyphenyl]-4-methylthiazole-5-carboxylic acid; 2-[3-Cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid; 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid; Febuxostat (Polymorphs); 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid  
EINECS : NA
Grade Standard : Medicine Grade
Specification: 99%
Appearance: Off- white to white crystalline powder  
Standard  : Enterprise Standard
CAS.No.: 144060-53-7
Fomular Structure: USP2010 Top Quality Febuxostat
Usage: Medicine
Storage: Stored in cool & dry place
Kept away from strong light and heat
Shelf Life: 2 years when properly stored

 

 

Application

 

Febuxostat (INN; trade names Adenuric [EU], Febutaz [India] and Uloric [US]) is a urate lowering drug, an inhibitor of xanthine oxidase that is indicated for use in the treatment of hyperuricemia and chronic gout.

Febuxostat received marketing approval by the European Medicines Agency on April 21, 2008 and was approved by the U.S. Food and Drug Administration on February 16, 2009.

A study comparing febuxostat to allopurinol found that more individuals treated with febuxostat had decreased levels of uric acid, but there was no difference in the amount of initial gout flares or the surface area of gout tophi.

 

 

 

Our Factory

 

Quality control

Shipment

 

Related Searches

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View